Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, South Sudan

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 97, Issue 2, 2003, Pages 229-235

  van den Broek, Ingrid V F ^a,d   Gatkoi, T ^a   Lowoko, B ^a   Nzila, A ^b,c   Ochong, E ^b   Keus, K ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d MSF   (Netherlands)

Author keywords

Amodiaquine; Chemotherapy; Chloroquine; Genotype; Malaria; Plasmodium falciparum; Resistance; South Sudan; Sulfadoxine pyrimethamine

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FANSIDAR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FEVER; FOLLOW UP; GENE MUTATION; GENOTYPE; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; PARASITE ISOLATION; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PRURITUS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RASH; SINGLE DRUG DOSE; SUDAN; TREATMENT FAILURE; WILD TYPE;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0142061643     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(03)90128-3     Document Type: Article

References (32)

1. Alene, G. D. & Bennet, S. (1996). Chloroquine resistance of Plasmodium falciparum malaria in Ethiopia and Eritrea. Tropical Medicine and International Health, 1, 810-815.
2. Allan, R. (2001). Roll Back Malaria - facing the challenges in complex emergencies. The Health Exchange, December 2001, pp. 4-6.
3. Bean, J. (2001). Insecticide Treated Bednet Trials, Lankien, Bieh State, Upper Nile, S-Sudan. Oxford: Oxfam-UK Report.
4. Bloland, P. B., Kazembe, P. N., Oloo, A. J., Himongo, B., Barat, L. M. & Ruebush, T. K. (1998). Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Tropical Medicine and International Health, 3, 543-552.
5. Campbell, M. & Machin, D. (1999). Medical Statistics, a Common Sense Approach, 3rd edition. Chichester: Wiley & Sons.
6. EANMAT (1999). In Vivo Anti Malaria Drug Efficacy Tests. Field Workers Guide/Manual, 1st edition. Nairobi, East Africa Network for Monitoring Antimalarial Treatment.
7. El Gadal, A. A. (1991). Malaria in the Sudan. Sub-Saharan Africa Programme: Malaria and Development in Africa, a Cross-sectoral Approach. Stanford: American Association for the Advancement of Science.
8. Gorissen, E., Ashruf, G., Lamboo, M., Bennebroek, J., Gikunda, S., Mbaruku, G. & Kager, P. (2000). In vivo efficacy study of amiodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Tropical Medicine and International Health, 5, 459-463.
9. Hastings, I. M. (2001). Modelling parasite drug resistance: lessons for management and control strategies. Tropical Medicine and International Health, 6, 883-890.
10. Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., Mukadam, R. A., Rogerson, S. J., Lescano, A., Molyneux, M. E., Winstanley, P. A., Chimpeni, P., Taylor, T. E. & Plowe, C. V. (2002). Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases, 185, 380-388.
11. MARA/ARMA (1998). Towards an Atlas of Malaria Risk in Africa. First Technical Report. Durban: Mapping Malaria Risk in Africa/Atlas du Risque de la Malaria en Afrique.
12. Mberu, E. K., Mosobo, M. K., Nzila, A. M., Kohwaro, G. O., Sibley, C. H. & Watkins, W. M. (2000). The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. American Journal of Tropical Medicine and Hygiene, 62, 396-401.
13. Médocins du Monde (1996). Field research, relief work and war: does chloroquine-resistance occur in displaced populations of southern Sudan? Tropical Doctor, April 1996, pp. 89-90.
14. Mutabingwa, T., Nzila, A., Mberu, E., Nduati, E., Winstanley, P., Hills, E. & Watkins W. (2001). Chlorproguanildapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet, 358, 1218-1223.
15. NMA (1998). The National Protocol for Treatment of Malaria, Republic of the Sudan, Federal Ministry of Health. Khartoum: National Malaria Administration.
16. NMA/UNICEF (1999). Report on Sentinel Sites. Khartoum. National Malaria Administration.
17. Nour, B. Y. M. (1999). In vitro/in vivo study to assess the response of P. falciparum to chloroquine, sulphadoxine/ pyrimethamine, quinine and mefloquine in Medani Sudan. MSc thesis, University of Khartoum, Sudan.
18. Nzila, A., Mberu, E., Sulo, J., Dayo, H., Winstanley, P., Sibley, C. & Watkins W. (2000a). Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in P. falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrobial Agents and Chemotherapy, 44, 991-996.
19. Nzila, A. M., Nduatu, E., Mberu, E. K., Sibley, C., Monk, S. A., Winstanley, P. A. & Watkins, W. M. (2000b). Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethamine/sulfadoxine compared with the shorter-acting chlorproguanil/ dapsone on Kenyan Plasmodium falciparum. Journal of Infectious Diseases, 181, 2023-2028.
20. Olliaro, P., Nevill, C., LeBras, J., Ringwald, P., Mussano, P., Garner, P. & Na Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 348, 1196-1201.
21. Omar, S. A., Adagu, I. S. & Warhurst, D. C. (2001). Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 315-319.
22. Price, R., Nosten, F. & Luxemburger, C. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet, 347, 1654-1658
23. Rønn, A., Msangeni, H., Mhina, J., Wernsdorfer, W. & Bygbjerg, I. C. (1996). High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 179-181.
24. Sibley, C. H., Hyde, J. E., Sims, P. F., Plowe, C. V., Kublin, J. G., Mberu, E. K., Cowman, A. F., Winstanley, P. A., Watkins, W. M. & Nzila, A. M. (2001). Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology, 17, 570-571.
25. Staedke, S. G., Kamya, M. R., Dorsey, G., Gasasira, A., Ndeezi, G., Charlebois, E. D. & Rosenthal, P. J. (2001). Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet, 358, 368-374.
26. Von Seidlein, L., Milligan, P., Pinder, M., Bojang, K., Anyalebechi, C., Gosling, R., Coleman, R., Ude, J. I., Sadiq, A., Duraisingh, M., Warhurst, D., Alloueche, A., Targett, G., McAdam, K., Greenwood, B., Walraven, G., Olliaro, P. & Doherty, T. (2000). Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet, 355, 352-357.
27. Watkins, W. M. & Mosobo, M. (1993). Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 75-78.
28. White, N. J., Nosten, F., Looareesuwan, S., Watkins, W. M., Marsh, K., Snow, R. W., Kokwaro, G., Ouma, J., Hien, T. T., Molyneux, M. E., Taylor, T. E., Newbold, C. I., Ruebush, T. K., Danis, M., Greenwood, B. M., Anderson, R. M. & Olliaro, P. (1999). Averting a malaria disaster. Lancet, 353, 1965-1967.
29. WHO (1991). Basic Malaria Microscopy - Laboratory Manual. Geneva: World Health Organization.
30. WHO (1996). Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Geneva: World Health Organization, WHO/MAL/96.1077.
31. WHO/CDS/RBM (2000). RBM Complex Emergency Malaria Data Base Sudan, update July 2000. Geneva: World Health Organization, CD-ROM.
32. WHO (2002). WWO Urges Countries to Act on New Anti-resistance Malaria Medicine. Geneva: World Health Organization, Press Release, WHO/31, 25 April 2002.